deaths (OS)

mNSCLC - L2 - PDL1 positive metastatic/advanced NSCLC (mNSCLC) - 2nd line (L2) mNSCLC - L2 - PDL1 positive

versus docetaxel
pembrolizumab (2mg/kg) vs. docetaxel 2 -874 [-1498; -251] /10000
230/483 vs. 279/495